Skip to main content

Ivan K. Blumenthal

Member

[email protected]

+1.212.692.6784

Share:

Ivan is a corporate and securities attorney who steers all types of deals and capital markets transactions work for underwriters, companies, and investors. He skillfully represents parties in a panoply of critical business transactions, including initial and follow-on public offerings, private investment in public equity (PIPE) transactions, mergers and acquisitions, and equity and debt financings. Public companies also seek his guidance on issues such as compliance and corporate governance matters and SEC disclosure requirements. Although he devotes much of his practice to the life sciences sector, his client roster also includes technology and consumer product companies.

Ivan’s practice focuses on corporate and securities law matters, primarily for life sciences and technology companies. Ivan has represented public and private companies, underwriters, venture capital funds, angel investors, and other parties in a broad range of transactions, including initial and follow-on public offerings, mergers and acquisitions, and equity and debt financings.

Ivan also devotes a significant portion of his practice to counseling public companies with respect to SEC disclosure, compliance, and corporate governance matters.

He also has extensive experience with negotiating stock and asset purchase agreements, employment and consulting contracts as well as stockholder, partnership, joint venture, and limited liability company agreements. Ivan regularly handles all aspects of corporate formation, license and distribution agreements, outsourcing, asset purchase, stock purchase and merger agreements, and other general corporate matters.

During law school, he was a member of St. John’s Law Review.

viewpoints

My colleagues Ivan Blumenthal and Robert Gault just published an Alert describing a recent decision of the Massachusetts Supreme Judicial Court pertaining to a challenge to a company’s imposition of certain fees and costs on service providers it classified as franchisees/independent contractors.
Read more
Read less

News & Press

Press Release Thumbnail Mintz
In the latest guide, Mintz garnered rankings as a top national firm in eight practice areas, and 32 firm attorneys were individually recognized.
Read less

Events & Speaking

Panelist
Mar
20
2019

Oppenheimer & Co.'s 29th Annual Healthcare Conference

The Westin New York Grand Central, New York

Speaker
Mar
21
2018

Oppenheimer & Co.'s 28th Annual Healthcare Conference

Westin Grand Central Hotel 212 East 42nd Street New York, NY

Speaker
Nov
17
2015
Read less

Ivan is a corporate and securities attorney who steers all types of deals and capital markets transactions work for underwriters, companies, and investors. He skillfully represents parties in a panoply of critical business transactions, including initial and follow-on public offerings, private investment in public equity (PIPE) transactions, mergers and acquisitions, and equity and debt financings. Public companies also seek his guidance on issues such as compliance and corporate governance matters and SEC disclosure requirements. Although he devotes much of his practice to the life sciences sector, his client roster also includes technology and consumer product companies.

Recognition & Awards

  • Recommended by The Legal 500 United States for Capital Markets: Equity (2020)

Read less